PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm

MedPharm Names Christy Mocny Vice President of Quality

MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, has appointed Christy Mocny as Vice President of Quality. The appointment strengthens MedPharm’s executive leadership and underscores the company’s commitment to quality, regulatory compliance and operational excellence. 

Ms. Mocny brings more than 20 years of experience in pharmaceutical and medical device quality management, regulatory compliance, and global Quality Management Systems (QMS). She most recently served as Director of Corporate Quality, Global Audits & Compliance at Biogen, where she led global audit programmes and initiatives focused on inspection readiness, quality systems, and enterprise-wide compliance.  

In her new role, Ms. Mocny will lead MedPharm’s Global Quality organisation, overseeing quality systems, regulatory compliance, and audit and inspection readiness. She will also direct quality assurance operations supporting pharmaceutical development, analytical services, clinical trial materials, and commercial manufacturing. 

“I am delighted to join MedPharm at such an exciting time for the business,” said Christy Mocny, Vice President of Quality, MedPharm. “I look forward to building on the organization’s strong quality foundations, advancing its systems and processes, and collaborating across the business to support continued growth and success.” 

“We are pleased to welcome Christy to MedPharm,” said Bill Humphries, Chief Executive Officer, MedPharm. “Her extensive experience in quality management and regulatory compliance, together with her enterprise leadership approach, will be a valuable asset in support of MedPharm’s accelerating rate of growth. Strong quality, and quality leadership at MedPharm is central to our success, and I am confident that Christy will help strengthen our organization and support its future growth.” 

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC